Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Cox-2 significantly contributes to the development and progression of skin and esophageal cancers.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Taking Propecia might lead to the development of cataracts.

Sox10 is important for hair follicle development and hair growth cycles.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

Hydrogel-based methods improve skin organoid development for medical and research applications.

A protein called sFRP4 from skin cells stops the development of pigment-producing cells in hair.

c-Kit is important for heart regeneration and cancer development.

Type I interferons play a key role in the development of various skin diseases.

Proper control of β-catenin activity is crucial for development and preventing diseases like cancer.

Human scalp fat stem cells showed improved cartilage-like development on a special scaffold with freeze-thaw treatment.

3D models and organoids improve liposarcoma research and therapy development.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Decreased IGF-1R expression may contribute to sacrococcygeal pilonidal sinus development.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

The digital system for measuring melasma shows promise but needs more development for better accuracy and automation.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.